LCTX:NYSEAMERICAN
BioTime
1,44 US$
arrow_downward
-6,21%(-0,095) 1 d
4 may, 15:54:47 GMT-4 · USD
search
Todos los símbolos
1 d
5 d
1 m
6 m
YTD
1 a
5 a
MÁX.
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de LCTX...
Abrir
1,50 US$
Alto
1,52 US$
Bajo
1,40 US$
Cap. merc.
356,50 M
Vol. medio
1,13 M
Volumen
2,15 M
Máximo en 52 sem.
2,09 US$
Mínimo en 52 sem.
0,42 US$
BPA
-0,28 US$
Beta
1,60
Acciones en circulación
249,09 M
N.º de empleados
75
Noticias
De fuentes de la Web
GuruFocus
·
hace 4 horas
LCTX Maintained by D. Boral Capital -- Price Target at $3.00
Stock Titan
·
hace 7 horas
Vision gains lasted 3 years after a single OpRegen treatment
Perfil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Acerca de BioTime
El contenido generado por IA puede contener errores. Más información